AKT1 and cancer: By integrating unbiased multi‐omics approaches, we have demonstrated the potential of volatile metabolites secreted from cancer and normal cells to be immunological mediators that activate numerous signaling pathways in monocytes, such as (PI3K)/protein kinase B (AKT) signaling pathway (Figure 5).